Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2010 Dec;51(12):6906; author reply 6906-7.
doi: 10.1167/iovs.10-6275.

Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma

Comment

Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma

Rajesh K Sharma et al. Invest Ophthalmol Vis Sci. 2010 Dec.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Sharma HS, Tang ZH, Gho BCG, Verdouw PD. Nucleotide sequence and expression of the porcine vascular endothelial growth factor. Biochim Biophys Acta. 1995;1260:235–238 - PubMed
    1. National Library of Medicine Medical Subject Headings 2009; MeSH Blocking+Antibodies. Available at: http://www.nlm.nih.gov/cgi/mesh/2009/MB_cgi?mode=&term=Blocking+Antibodies Accessed
    1. Hook LM, Huang J, Jiang M, Hodinka R, Friedman HM. Blocking antibody access to neutralizing domains on glycoproteins involved in entry as a novel mechanism of immune evasion by herpes simplex virus type 1 glycoproteins C and E. J Virol. 2008;82:6935–6941 - PMC - PubMed
    1. Bock F, Onderka J, Dietrich T, et al. Bevacizumab as a potent inhibitor of inflammatory corneal angiogensis and lymphangiogenesis. Invest Ophthalmol Vis Sci. 2007;48:2545–2552 - PubMed
    1. Hua J, Spee C, Kase S, et al. Recombinant human VEGF165b inhibits experimental choroidal neovascularization. Invest Ophthalmol Vis Sci. 2010;51:4282–4288 - PMC - PubMed

MeSH terms